TAZORAC - 0023-8335-03 - (tazarotene)

Alphabetical Index


Drug Information of TAZORAC

Product NDC: 0023-8335
Proprietary Name: TAZORAC
Non Proprietary Name: tazarotene
Active Ingredient(s): .5    mg/g & nbsp;   tazarotene
Administration Route(s): CUTANEOUS
Dosage Form(s): GEL
Coding System: National Drug Codes(NDC)

Labeler Information of TAZORAC

Product NDC: 0023-8335
Labeler Name: Allergan, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020600
Marketing Category: NDA
Start Marketing Date: 19970801

Package Information of TAZORAC

Package NDC: 0023-8335-03
Package Description: 1 TUBE in 1 CARTON (0023-8335-03) > 30 g in 1 TUBE

NDC Information of TAZORAC

NDC Code 0023-8335-03
Proprietary Name TAZORAC
Package Description 1 TUBE in 1 CARTON (0023-8335-03) > 30 g in 1 TUBE
Product NDC 0023-8335
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name tazarotene
Dosage Form Name GEL
Route Name CUTANEOUS
Start Marketing Date 19970801
Marketing Category Name NDA
Labeler Name Allergan, Inc.
Substance Name TAZAROTENE
Strength Number .5
Strength Unit mg/g
Pharmaceutical Classes Retinoid [EPC],Retinoids [Chemical/Ingredient]

Complete Information of TAZORAC


General Information